| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
7 companies
Patrick G Enright is Director, 10% Owner at MANE and has filed Form 4s across 7 companies. From March 2015 to August 2026, the filings on record show 9 open-market purchases and 22 sales. Patrick G Enright's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $301.5M at current prices.
Historically, Patrick G Enright's trades have earned a strong insider score of 71/100 across 13 rated trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +11.7%.
The biggest single holding is MANE (~$274.4M) as Director, 10% Owner. Net of sales, the MANE filings show accumulation of 1,075,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2017 | CORT Corcept Therapeutics Inc | Director | Sell | 269,955 | $9.94 | $2,683,236.76 | -70.2% | |
| Mar 15, 2017 | CORT Corcept Therapeutics Inc | Director | Sell | 600,000 | $10.15 | $6,092,927.07 | -81.1% | |
| Mar 8, 2017 | CORT Corcept Therapeutics Inc | Director | Sell | 750,000 | $9.75 | $7,312,500.00 | -83.2% | |
| Feb 27, 2017 | CORT Corcept Therapeutics Inc | Director | Sell | 2,500,000 | $8.81 | $22,025,000.00 | -93.8% | |
| Dec 2, 2016 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 677 | $101.80 | $68,918.60 | -33.2% | |
| Nov 25, 2016 | CORT Corcept Therapeutics Inc | Director, 10% Owner | Sell | 36,941 | $9.34 | $345,165.29 | -17.0% | |
| Nov 21, 2016 | CORT Corcept Therapeutics Inc | Director, 10% Owner | Sell | 544,100 | $9.56 | $5,199,426.21 | -75.1% | |
| Nov 16, 2016 | CORT Corcept Therapeutics Inc | Director, 10% Owner | Sell | 174,847 | $9.55 | $1,669,605.82 | -47.7% | |
| Aug 15, 2016 | JAZZ Jazz Pharmaceuticals Plc | Director | Sell | 633 | $136.45 | $86,372.85 | -23.7% | |
| Mar 24, 2015 | CORT Corcept Therapeutics Inc | Director, 10% Owner | Sell | 1,089,745 | $5.75 | $6,264,138.65 | -7.4% |